Tesla Model S HYPE Continues to Build Strength and 4 More HOT Analyst Insights
Abercrombie & Fitch Co. (NYSE:ANF) possesses visible growth, strong cash flow generation, and margin growth Jefferies said after management meetings. The firm sees attractive valuation. The firm maintains its Buy rating but dropped the price target from $70 to $60 on the shares.
Tesla Motors, Inc. (NASDAQ:TSLA): According to Jefferies, the Model S by Tesla is the highest performing performance sedan for less than $100K. The firm predicts good media reports on the sedan and maintains confidence it its sales target of 5000 units. The firm gives a Buy rating with a $39 price target on the stock.
Don’t Miss: Is Chesapeake GUILTY of This DAMNING Charge?
American Vanguard Corp. (NYSE:AVD): Recent channel checks indicate the American Vangard is ready for a powerful Q4 after Q2, but seasonality may weaken Q3 results, according to Piper Jaffray. The firm maintains an Overweight rating a $30 price target on the stock.
Watson Pharmaceuticals Inc. (NYSE:WPI): General Adderall XR and its generic counterpart Actavis, currently being acquired by Watson Pharmaceuticals, have been approved by the FDA. This news supports Goldman’s over consensus earnings estimates for the pharmaceutical company, and it predicts a small impact for Teva (NASDAQ:TEVA) and Impax (NASDAQ:IPXL).
Zynga (NASDAQ:ZNGA): According to Baird, clarity should be added to Zynga’s potential growth drivers for an upcoming showcase event which includes the company’s diverse game pipeline, Zynga.com gaming platform updates, and advertising opportunities. The firm gives shares an Ouperform rating and a $13 price target.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.